ERBB2 and cancer: First, although population-based cancer registries provided a lot of information to the SEER database, data on HER-2 status were recorded only since 2010; therefore, among the 842 patients, only 68 had HER-2 records, which prevented the identification of the molecular subgroup of BC and may cause bias on the analyzing of HER-2.